Outbound Pharma, a boutique firm in the life sciences sector known for business development and lead generation, is launching "Meet For Epilepsy", an innovative fundraising initiative. This unique campaign is set to channel funds into the Epilepsy Foundation, marking a significant stride in the fight against epilepsy.
Dr. Claudio Rota, Founder and Managing Director of Outbound Pharma, expressed his enthusiasm about the collaboration, stating: "Launching our Meet For Epilepsy campaign in partnership with the Epilepsy Foundation is a thrilling way to commence the new year. Our goal is to not only bolster the foundation's commendable efforts in raising epilepsy awareness and mobilizing action but also to foster greater collaboration and dialogue within the life sciences industry."
This initiative highlights Outbound Pharma's commitment to using its industry influence for a noble cause by inspiring and engaging service providers, biotech, and pharma companies in a united front against epilepsy.
A History of Giving
Since its establishment in 2017, Outbound Pharma has advocated for various noble causes, including the fight against animal testing in scientific research. The Meet For Epilepsy campaign is the company's latest philanthropic venture, aiming to heighten awareness and understanding of epilepsy.
Meet for Epilepsy: A Synergistic Approach
Beyond fundraising, the partnership between Outbound Pharma and the Epilepsy Foundation serves a broader purpose. It is designed to accelerate collaborations and partnerships between industry players, service providers, and the biopharmaceutical community at large.
Oksana Kryvenchuk, the Head of Marketing at Outbound Pharma, emphasizes the importance of this campaign in sparking meaningful discussions across all levels of the industry. She explains the most pressing challenge faced by the industry: "The process of engaging the right stakeholders in our field can be challenging," she notes. "Finding suitable partners for drug discovery, commercialization, or regulatory support can be difficult, and the current methods can be time-consuming and inefficient. We aim to revolutionize this process."
The Meet For Epilepsy fundraiser serves a dual purpose, supporting the noble cause of the Epilepsy Foundation while also fostering productive meetings and partnerships between life science companies. The partnership's primary goal is multifaceted: fundraising, facilitating dialogue and driving meetings and collaborations.
For every meeting Outbound Pharma schedules between industry partners, Outbound Pharma will donate 10% to the Epilepsy Foundation.
About Outbound Pharma
Outbound Pharma is a life sciences consultancy offering a full suite of services designed to empower your business development and partnering efforts. From lead generation to multi-pronged business development and marketing, we have the expertise you need to stay ahead and build more connections.
Why Outbound Pharma:
Proven Track Record: With a stellar track record of delivering leads for clients across the life science industry, we know what it takes to turn challenges into triumphs.
Holistic Approach: Our comprehensive suite of business development and marketing services ensures we can meet all your partnering needs under one roof, saving you money, time, and effort.
Cutting-Edge Technology Stack: Stay ahead of the competition with our comprehensive suite of lead-gen tools designed to leverage the latest technologies and industry best practices.
Client-Centric Focus: Your success is our success. We pride ourselves on our client-centric approach, with a win-win engagement model designed to maximize your return on investment without the upfront costs.
About Epilepsy
According to the World Health Organization, epilepsy is the most common serious brain disorder worldwide with no age, racial, social class, national or geographic boundaries. The U.S. Centers for Disease Control & Prevention (CDC) estimates that 3.4 million people in the United States are affected by epilepsy. Epilepsy is the underlying tendency of the brain to produce seizures which are sudden abnormal bursts of electrical energy that disrupt brain functions.
About the Epilepsy Foundation
With a network of partners throughout the United States, the Epilepsy Foundation is leading the fight to overcome the challenges of living with epilepsy. The Foundation connects people to treatment, support and resources; leads advocacy efforts; funds innovative research and the training of specialists; and educates the public about epilepsy and seizure first aid. For more than five decades, the Epilepsy Foundation has shone a light on epilepsy to promote awareness and understanding, and to advocate for laws that matter to people with epilepsy, while also funding epilepsy research and supporting epilepsy investigators and specialists in their early careers. In partnership with the CDC, the Epilepsy Foundation
has helped to improve access to care for people with epilepsy, expanded its digital reach and online resources in homes across the country, and trained more than 600,000 people in seizure recognition and first aid. The Epilepsy Foundation continues to focus on serving the epilepsy community through advocacy, education, direct services and research for new therapies. To learn more visit epilepsy.com or call 1.800.332.1000. Follow us on Facebook and Twitter.
Commentaires